Residual DNA in COVID-19 mRNA vaccines: Regulatory context and misinformation
Authors:
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impuritiesnpj Vaccines, 2025
- Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, CanadaAutoimmunity, 2025
- Opting for the appropriate methodology for quantification of residual DNA impurities in mRNA vaccinesVaccine, 2025
- Quantification of objective concentrations of DNA impurities in mRNA vaccinesVaccine, 2025
- Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®Methods and Protocols, 2024
- High spontaneous integration rates of end-modified linear DNAs upon mammalian cell transfectionScientific Reports, 2023
- Exosome-mediated horizontal gene transfer occurs in double-strand break repair during genome editingCommunications Biology, 2019